Madrigal Pharmaceuticals, Inc. (MDGL)
439.16
+4.36
(+1.00%)
USD |
NASDAQ |
Mar 05, 15:14
Madrigal Pharmaceuticals Cash from Investing (Quarterly) : 27.58M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Insmed, Inc. | 389.41M |
| Pfizer Inc. | -6.146B |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Eli Lilly & Co. | -2.802B |
| Johnson & Johnson | -4.485B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -133.46M |
| Cash from Financing (Quarterly) | 8.956M |
| Free Cash Flow | -193.02M |
| Free Cash Flow Per Share (Quarterly) | -5.829 |
| Free Cash Flow to Equity (Quarterly) | -134.30M |
| Free Cash Flow to Firm (Quarterly) | -124.77M |
| Free Cash Flow Yield | -1.96% |